Human Autoantigen Atlas: Searching for the Hallmarks of Autoantigens.

Understanding autoimmunity to endogenous proteins is crucial in diagnosing and treating autoimmune diseases. In this work, we developed a user-friendly AAgAtlas portal (http://biokb.ncpsb.org.cn/aagatlas_portal/index.php#), which can be used to search for 8045 non-redundant autoantigens (AAgs) and 47 post-translationally modified AAgs against 1073 human diseases that are prioritized by a credential score developed by multisource evidence. Using AAgAtlas, the immunogenic properties of human AAgs was systematically elucidated according to their genetic, biophysical, cytological, expression profile, and evolutionary characteristics. The results indicated that human AAgs are evolutionally conserved in protein sequence and enriched in three hydrophilic and polar amino acid residues (K, D, and E) that are located at the protein surface. AAgs are enriched in proteins that are involved in nucleic acid binding, transferase, and the cytoskeleton. Genome, transcriptome, and proteome analyses further indicated that AAb production is associated with gene variance and abnormal protein expression related to the pathological activities of different tumors. Collectively, our data outlines the hallmarks of human AAgs that facilitate the understanding of humoral autoimmunity and the identification of biomarkers of human diseases.

[1]  A. Iwasaki,et al.  Antibodies against human endogenous retrovirus K102 envelope activate neutrophils in systemic lupus erythematosus , 2021, The Journal of experimental medicine.

[2]  H. Prüss Autoantibodies in neurological disease , 2021, Nature Reviews Immunology.

[3]  T. Hampton Autoantibodies May Drive COVID-19 Blood Clots. , 2021, JAMA.

[4]  R. Frank,et al.  Autoantibody Formation and Mapping of Immunogenic Epitopes against Cold-Shock-Protein YB-1 in Cancer Patients and Healthy Controls , 2020, Cancers.

[5]  Steven M. Holland,et al.  Autoantibodies against type I IFNs in patients with life-threatening COVID-19 , 2020, Science.

[6]  P. Xing,et al.  Autoantibody profiling identifies predictive biomarkers of response to anti-PD1 therapy in cancer patients , 2020, Theranostics.

[7]  H. Fried,et al.  Proteins in assemblages formed by phase separation possess properties that promote their transformation to autoantigens: Implications for autoimmunity. , 2020, Journal of autoimmunity.

[8]  A. Flöel,et al.  Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons , 2020, Autoimmunity Reviews.

[9]  Xiaobo Yu,et al.  SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution , 2020, bioRxiv.

[10]  Stéphane Paul,et al.  Autoantigenomics: Holistic characterization of autoantigen repertoires for a better understanding of autoimmune diseases. , 2019, Autoimmunity reviews.

[11]  S. Aouichat-Bouguerra,et al.  Activation of coagulation in patients with lung cancer. , 2019, Annales de biologie clinique.

[12]  Jonathan L. Robinson,et al.  A Systematic Investigation of the Malignant Functions and Diagnostic Potential of the Cancer Secretome , 2019, Cell reports.

[13]  J. Sugisaka,et al.  Profiling Preexisting Antibodies in Patients Treated With Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer , 2019, JAMA oncology.

[14]  Ying Jiang,et al.  A two-level model for the role of complex and young genes in the formation of organism complexity and new insights into the relationship between evolution and development , 2018, EvoDevo.

[15]  Z. Tezak,et al.  Right data for right patient—a precisionFDA NCI–CPTAC Multi-omics Mislabeling Challenge , 2018, Nature Medicine.

[16]  J. Jett,et al.  Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules , 2018, PloS one.

[17]  O. Koren,et al.  Molecular (Me)micry? , 2018, Cell host & microbe.

[18]  Sheng Liu,et al.  AAgMarker 1.0: a resource of serological autoantigen biomarkers for clinical diagnosis and prognosis of various human diseases , 2017, Nucleic Acids Res..

[19]  L. Gaboury,et al.  HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma , 2017, Oncotarget.

[20]  Raghavan Varadarajan,et al.  Mapping Protein Binding Sites and Conformational Epitopes Using Cysteine Labeling and Yeast Surface Display. , 2017, Structure.

[21]  Dan Wang,et al.  AAgAtlas 1.0: a human autoantigen database , 2016, Nucleic Acids Res..

[22]  Tsippi Iny Stein,et al.  The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses , 2016, Current protocols in bioinformatics.

[23]  M. Ziman,et al.  Autoantibody Production in Cancer--The Humoral Immune Response toward Autologous Antigens in Cancer Patients. , 2016, Autoimmunity reviews.

[24]  Zhao Li,et al.  Identification of 14-3-3 Proteins Phosphopeptide-Binding Specificity Using an Affinity-Based Computational Approach , 2016, PloS one.

[25]  Yosvany López,et al.  HitPredict version 4: comprehensive reliability scoring of physical protein–protein interactions from more than 100 species , 2015, Database J. Biol. Databases Curation.

[26]  A. Kukushkin,et al.  Detection of Early Cancer: Genetics or Immunology? Serum Autoantibody Profiles as Markers of Malignancy. , 2015, Anti-cancer agents in medicinal chemistry.

[27]  Jian-Rong Yang,et al.  Determinants of the rate of protein sequence evolution , 2015, Nature Reviews Genetics.

[28]  P. Emery,et al.  Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis , 2014, Mediators of inflammation.

[29]  W. Robinson,et al.  Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 ‘shared epitope’ alleles , 2013, Annals of the rheumatic diseases.

[30]  Heather A. Carlson,et al.  Exploring the Composition of Protein-Ligand Binding Sites on a Large Scale , 2013, PLoS Comput. Biol..

[31]  George M Church,et al.  pLogo: a probabilistic approach to visualizing sequence motifs , 2013, Nature Methods.

[32]  H. Bull,et al.  Erosive Rheumatoid Arthritis Is Associated with Antibodies That Activate PAD4 by Increasing Calcium Sensitivity , 2013, Science Translational Medicine.

[33]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[34]  Jian-Rong Yang,et al.  Differential requirements for mRNA folding partially explain why highly expressed proteins evolve slowly , 2013, Proceedings of the National Academy of Sciences.

[35]  D. Marks,et al.  Diagnosis of ADHD in Adults , 2012, Journal of attention disorders.

[36]  Dong Li,et al.  General trends in the utilization of structural factors contributing to biological complexity. , 2012, Molecular biology and evolution.

[37]  Yun-ping Zhu,et al.  Regular Patterns for Proteome-Wide Distribution of Protein Abundance across Species , 2012, PloS one.

[38]  Yang Xia,et al.  Receptor-activating autoantibodies and disease: preeclampsia and beyond , 2011, Expert review of clinical immunology.

[39]  Christina Backes,et al.  Immunogenicity of autoantigens , 2011, BMC Genomics.

[40]  Fengchun Zhang,et al.  Prevalence of Autoimmune Liver Disease Related Autoantibodies in Chinese Patients with Primary Biliary Cirrhosis , 2011, Digestive Diseases and Sciences.

[41]  K. Chou,et al.  Prediction of Antimicrobial Peptides Based on Sequence Alignment and Feature Selection Methods , 2011, PloS one.

[42]  Pornpimol Charoentong,et al.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..

[43]  Markus Steiner A Common Pathway for All Autoimmune Diseases? The Unholy Alliance of Environment, Cell Death and Nucleic Acids , 2009 .

[44]  S. Teichmann,et al.  Tight Regulation of Unstructured Proteins: From Transcript Synthesis to Protein Degradation , 2008, Science.

[45]  Daniel Thomas,et al.  Recognition and Degradation of Myelin Basic Protein Peptides by Serum Autoantibodies: Novel Biomarker for Multiple Sclerosis1 , 2008, The Journal of Immunology.

[46]  M. Malaise,et al.  Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[47]  L. Sansing,et al.  A patient with encephalitis associated with NMDA receptor antibodies , 2007, Nature Clinical Practice Neurology.

[48]  Zsuzsanna Dosztányi,et al.  IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content , 2005, Bioinform..

[49]  Martin Kuiper,et al.  BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks , 2005, Bioinform..

[50]  P. Lollar,et al.  Pathogenic antibodies to coagulation factors. Part II. Fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, the protein C system and von Willebrand factor , 2005, Journal of thrombosis and haemostasis : JTH.

[51]  C. Wilke,et al.  Why highly expressed proteins evolve slowly. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Michael B. Stadler,et al.  Single nucleotide polymorphisms as a prerequisite for autoantigens , 2005, European journal of immunology.

[53]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[54]  M. Campbell,et al.  PANTHER: a library of protein families and subfamilies indexed by function. , 2003, Genome research.

[55]  J. Zunt,et al.  Autoimmunity due to molecular mimicry as a cause of neurological disease , 2002, Nature Medicine.

[56]  S. Tickoo,et al.  Discriminant nuclear features of renal oncocytoma and chromophobe renal cell carcinoma. Analysis of their potential utility in the differential diagnosis. , 1998, American journal of clinical pathology.

[57]  E. Tan,et al.  Autoantibody to centromere (kinetochore) in scleroderma sera. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[58]  E. Tan,et al.  Autoantibody to a nuclear antigen in proliferating cells. , 1978, Journal of immunology.

[59]  Prof. Naruya Saitou Introduction to Evolutionary Genomics , 2018, Computational Biology.

[60]  E. Klang,et al.  A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. , 2015, Autoimmunity reviews.

[61]  Albert J. Vilella,et al.  EnsemblCompara GeneTrees: Complete, duplication-aware phylogenetic trees in vertebrates. , 2009, Genome research.

[62]  P. Plotz,et al.  The autoantibody repertoire: searching for order , 2003, Nature Reviews Immunology.